Search This Blog

Sharon Smith

FDA Approves Neoadjuvant Nivolumab/Chemo for Early-Stage NSCLC

Get link
Facebook
X
Pinterest
Email
Other Apps

March 04, 2022

The pathologic complete response rate was 24% versus 2.2% with chemotherapy alone.
FDA Approvals

source https://www.medscape.com/viewarticle/969733?src=rss

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

RA and RA-ILD Linked to Higher Lung Cancer Risk

August 09, 2024

Rheumatoid arthritis increased the risk for lung cancer, and this risk was threefold higher in patients with rheumatoid arthritis–associated interstitial lung disease. Medscape Medical News source https://www.medscape.com/viewarticle/rheumatoid-arthritis-and-ra-associated-interstitial-lung-2024a1000epm?src=rss

Study: 3D Total-body Imaging Improves Biopsy ‘Hit’ Rates

March 21, 2025

Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces unnecessary biopsies of skin lesions, a study showed. Medscape Medical News source https://www.medscape.com/viewarticle/3d-total-body-photography-shown-decrease-biopsies-improve-dx-2025a10006r7?src=rss

Heart Failure Care Outside of ICU Can Lower Cost

March 19, 2025

A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU is more cost effective, among other advantages. Medscape Medical News source https://www.medscape.com/viewarticle/heart-failure-care-outside-icu-can-lower-cost-2025a10006iy?src=rss